Reaction
Prostatic Specific Antigen Decreased reporting signals
As of the last recalculation, Prostatic Specific Antigen Decreased appears in 375 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is BICALUTAMIDE (PRR 81.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bicalutamide | 21 | 81.0 | 81.1 |
| Apalutamide | 14 | 68.6 | 68.7 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 15 | 65.8 | 65.8 |
| Abiraterone Acetate | 38 | 56.9 | 57.0 |
| Relugolix | 17 | 41.9 | 41.9 |
| Leuprolide Acetate | 47 | 38.3 | 38.3 |
| Enzalutamide | 35 | 36.3 | 36.4 |
| Abiraterone | 8 | 33.3 | 33.3 |
| Olaparib | 6 | 16.2 | 16.2 |